Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check3 days agoChange DetectedThe study's site list expanded to 476 locations, including Seattle (University of Washington Medical Center – Montlake), Santo André, Poznan, Pratia Poznan, and Nitra. The total locations increased from 472 to 476, dates were updated to 2025-12-02, 2026-08-01, and 2029-08-01, and extensive contact details were removed.SummaryDifference12%

- Check10 days agoChange DetectedRevision indicator updated: v3.3.2 added and v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision history updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check25 days agoChange Detected- Removed the government funding status notice from the page. This does not change the study details, eligibility criteria, or the listed outcomes.SummaryDifference0.0%

- Check40 days agoChange DetectedReplaced the Colombia site location 'Santiago de Cali, Valle del Cauca Department, Colombia, 760032' with 'Cali, Valle del Cauca Department, Colombia, 760032' in the Locations list, and added the label 'Last Update Posted (Estimated)' to reflect update timing.SummaryDifference0.1%

- Check54 days agoChange DetectedExpanded study footprint with 6 new locations across Europe and South America, bringing total sites to 472; updated status and last update timestamp. The page now reflects broader geographic coverage and updated location data.SummaryDifference1.0%

Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.